The prostate cancer experts at Duke Prostate and Urologic Cancer Center bring you today's leading-edge treatments to help you reach a healthier tomorrow.
At our center, specialists are members of Duke’s nationally-ranked urology and cancer programs and lead the field in screening, diagnosing and treating prostate cancer. The center is a collaborative powerhouse that uses the latest medical, surgical and radiation therapies to treat your prostate cancer. As a top referral center for prostate cancer, we specialize in difficult-to-treat prostate cancers.
Ready for an appointment? Please visit Duke Health.
The experts at Duke Prostate & Urologic Cancer Center specialize in diagnosing prostate cancer. Finding prostate cancer early and getting an accurate diagnosis are key to your health and outcomes. If you are experiencing symptoms, please consult your physician. Based on their evaluation, further testing may be ordered that can help in diagnosing and assessing cancer.
These tests can include:
Additional tests, such as genetic tests of tumor tissue, blood, and saliva, may be useful to more accurately predict your risk of aggressive cancer or recurrence after treatment, the chance that your prostate cancer may be hereditary, and how to best treat your cancer. These include tests such as Prolaris, Oncotype DX, and Decipher, as well as germline testing of saliva, tumor mutational profiling such as with Foundation Medicine or cell free plasma DNA testing. Ask your doctor if these tests may be helpful for your care.
Duke Prostate and Urologic Cancer Center offers a variety of minimally invasive treatments, such as:
Energy Ablative Technique:
We are also strong advocates of active surveillance for small, nonaggressive prostate cancer. Duke has an active surveillance registry and clinical program incorporating molecular testing of tumor tissue, prostate MRI, and lifestyle and dietary approaches to better identify men most likely to benefit from treatment and those who can safely defer therapy. We try to keep men on active surveillance until treatment is necessary and believe surveillance is a safe and important course for certain men with low risk prostate cancer. Some men are candidates for watchful waiting, where patients who are not candidates for surgery or radiation are carefully observed until treatment is needed.
Duke practices a first do no harm approach, optimizing treatment tailored to those men most likely to benefit while minimizing risks, and incorporates a multi-disciplinary team based approach to patient counseling, risk stratification, and therapy based on individual patient’s health conditions, prostate cancer subtypes, and preferences.
The multidisciplinary team includes surgeons, radiation oncologists and medical oncologists. The team explores all options, including active surveillance, before recommending surgical removal of your prostate or external radiation therapy.
We understand that each patient's cancer possesses unique characteristics that can manifest itself in a variety of behaviors and outcomes. Thus, we take a personalized approach to determine the best therapies for each individual patient, including utilizing precision medicine to examine a patient’s urine or blood-based biomarkers, tissue-based biomarkers and imaging biomarkers.
Breaking down traditional barriers to rapid innovation, our prostate cancer specialists are leading national research efforts while developing novel treatments. Clinical research is critical to our collective mission of reducing the burden of prostate cancer, and we're committed to designing better treatments and preventive approaches.
Duke is also one of only 10 institutions nationwide selected to participate in the Department of Defense's Prostate Cancer Clinical Trials Consortium, which facilitates patient enrollment in phase I and phase II clinical trials and improves drug development for prostate cancer. Duke also provides access to phase 3 clinical trials, registries, biomarker studies, and genetic testing and counseling for men with prostate cancer.
Duke Cancer Institute constellates the world-class resources of Duke University, Duke Health and the Duke Comprehensive Cancer Center into a collaborative powerhouse. We are poised to drive a paradigm shift in the way long-established cancer centers and institutes have been waging this war.Ways To Give